ALGN vs. EW: Align vs. Edwards Lifesciences Stock Comparison
How do Align (ALGN) and Edwards Lifesciences (EW) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Align (ALGN) and Edwards Lifesciences (EW) both belong to the Health Care Equipment & Supplies industry, though ALGN is classified under Health Care Supplies while EW falls under Health Care Equipment.
| Profile Item | ALGN | EW |
|---|---|---|
| Name | Align Technology Inc. | Edwards Lifesciences Corporation |
| Country/Region | United States | United States |
| GICS Sector | Health Care | Health Care |
| GICS Industry Group | Health Care Equipment & Services | Health Care Equipment & Services |
| GICS Industry | Health Care Equipment & Supplies | Health Care Equipment & Supplies |
| GICS Sub-Industry | Health Care Supplies | Health Care Equipment |
| Market Capitalization | 11.70 billion USD | 58.73 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | January 30, 2001 | March 27, 2000 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Calendar-Year Returns
Performance Metrics
| Metric | ALGN | EW |
|---|---|---|
| Total Return (1Y) | 27.43% | 25.08% |
| Total Return (3Y, Annualized) | -2.84% | 17.28% |
| Total Return (5Y, Annualized) | -24.73% | -2.77% |
Risk Profile
Drawdown History
Return Distribution
Risk Metrics
| Metric | ALGN | EW |
|---|---|---|
| Volatility (1Y, Annualized) | 40.49% | 25.58% |
| Beta (5Y) | 1.67 | 0.78 |
| Max Drawdown (5Y) | -82.44% | -54.32% |
| Avg. Volume (3M) | 942.14K | 3.69M |
Risk-Adjusted Performance
Risk-Return Positioning
Risk-Adjusted Metrics
| Metric | ALGN | EW |
|---|---|---|
| Sharpe Ratio (1Y) | 0.57 | 0.81 |
| Sortino Ratio (1Y) | 0.89 | 1.23 |
Profitability
ROE (TTM)
Both Align (ALGN) at 11.91% and Edwards Lifesciences (EW) at 9.33% land near their industries’ usual ROE ranges, so capital efficiency looks broadly in line with peers on both sides.
ALGN
Health Care Equipment & Services industry group
11.91%
- Max
- 47.61%
- Q3
- 14.36%
- ALGN
- 11.91%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
EW
Health Care Equipment & Services industry group
9.33%
- Max
- 47.61%
- Q3
- 14.36%
- EW
- 9.33%
- Median
- 5.45%
- Q1
- -10.67%
- Min
- -47.01%
Net Margin (TTM)
For every dollar of sales, both Align (ALGN) at 11.83% and Edwards Lifesciences (EW) at 15.30% retain more as net profit than most peers, landing in the top net margin quartile of their industries.
ALGN
Health Care Equipment & Services industry group
11.83%
- Max
- 29.35%
- ALGN
- 11.83%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
EW
Health Care Equipment & Services industry group
15.30%
- Max
- 29.35%
- EW
- 15.30%
- Q3
- 9.33%
- Median
- 2.18%
- Q1
- -6.29%
- Min
- -28.46%
Operating Margin (TTM)
Both Align (ALGN) at 20.13% and Edwards Lifesciences (EW) at 30.15% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
ALGN
Health Care Equipment & Services industry group
20.13%
- Max
- 35.43%
- ALGN
- 20.13%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
EW
Health Care Equipment & Services industry group
30.15%
- Max
- 35.43%
- EW
- 30.15%
- Q3
- 14.14%
- Median
- 6.81%
- Q1
- -0.28%
- Min
- -16.29%
Profitability Metrics
| Metric | ALGN | EW |
|---|---|---|
| ROE (TTM) | 11.91% | 9.33% |
| ROA (TTM) | 8.01% | 8.77% |
| Net Margin (TTM) | 11.83% | 15.30% |
| Operating Margin (TTM) | 20.13% | 30.15% |
| Gross Margin (TTM) | 71.53% | 78.02% |
Growth
Revenue Growth
Edwards Lifesciences (EW) at 11.55% is around its peer norm for revenue growth, while Align (ALGN) at 0.90% drops into the bottom quartile, signaling weaker demand or pricing momentum.
EPS Growth
Align (ALGN) at 0.53% is around its peer norm for EPS growth, while Edwards Lifesciences (EW) at -73.74% drops into the bottom quartile, signaling weaker earnings momentum.
Growth Metrics
| Metric | ALGN | EW |
|---|---|---|
| Revenue Growth (YoY) | 0.90% | 11.55% |
| Revenue Growth (3Y CAGR) | 2.61% | 10.77% |
| EPS Growth (YoY) | 0.53% | -73.74% |
| EPS Growth (3Y CAGR) | 7.02% | -9.14% |
Financial Strength
Current Ratio (MRQ)
Align (ALGN) at 1.43 keeps current ratio within its industry’s typical mid-range, while Edwards Lifesciences (EW) at 4.60 sits above its industry’s typical mid-range — comfortable liquidity, though possibly with more idle current assets relative to peers.
ALGN
Health Care Equipment & Services industry group
1.43
- Max
- 7.59
- Q3
- 4.00
- Median
- 1.98
- ALGN
- 1.43
- Q1
- 1.37
- Min
- 0.30
EW
Health Care Equipment & Services industry group
4.60
- Max
- 7.59
- EW
- 4.60
- Q3
- 4.00
- Median
- 1.98
- Q1
- 1.37
- Min
- 0.30
Debt / Equity (MRQ)
Both Align (ALGN) at 0.03 and Edwards Lifesciences (EW) at 0.06 keep leverage in the lower quartile of their industries, with less balance-sheet debt relative to equity than most peers.
ALGN
Health Care Equipment & Services industry group
0.03
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- ALGN
- 0.03
- Min
- 0.00
EW
Health Care Equipment & Services industry group
0.06
- Max
- 1.88
- Q3
- 0.91
- Median
- 0.58
- Q1
- 0.16
- EW
- 0.06
- Min
- 0.00
Financial Strength Metrics
| Metric | ALGN | EW |
|---|---|---|
| Current Ratio (MRQ) | 1.43 | 4.60 |
| Debt / Equity (MRQ) | 0.03 | 0.06 |
| Net Debt / EBITDA | -1.04 | -1.88 |
Dividends
Dividend Yield (TTM)
Neither Align (ALGN) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
ALGN
Health Care Equipment & Services industry group
0.00%
- ALGN
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Neither Align (ALGN) nor Edwards Lifesciences (EW) pays a dividend this period — they may reinvest, use buybacks, or simply not return cash through dividends.
ALGN
Health Care Equipment & Services industry group
0.00%
- ALGN
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
EW
Health Care Equipment & Services industry group
0.00%
- EW
- 0.00%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | ALGN | EW |
|---|---|---|
| Dividend Yield (TTM) | 0.00% | 0.00% |
| Dividend Payout Ratio (TTM) | 0.00% | 0.00% |
Valuation
P/E Ratio (TTM)
Align (ALGN) at 24.20 is near its industry’s usual P/E ratio, while Edwards Lifesciences (EW) at 59.38 sits in the richer quartile — EW needs stronger growth or earnings quality to justify the premium.
ALGN
Health Care Equipment & Services industry group
24.20
- Max
- 80.41
- Q3
- 47.62
- Median
- 29.93
- ALGN
- 24.20
- Q1
- 21.19
- Min
- 4.21
EW
Health Care Equipment & Services industry group
59.38
- Max
- 80.41
- EW
- 59.38
- Q3
- 47.62
- Median
- 29.93
- Q1
- 21.19
- Min
- 4.21
P/S Ratio (TTM)
Align (ALGN) at 2.81 is priced about in line with its industry on P/S ratio, while Edwards Lifesciences (EW) at 8.80 sits in the pricier quartile — EW costs more per dollar of sales.
ALGN
Health Care Equipment & Services industry group
2.81
- Max
- 8.80
- Q3
- 4.32
- ALGN
- 2.81
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
EW
Health Care Equipment & Services industry group
8.80
- EW
- 8.80
- Max
- 8.80
- Q3
- 4.32
- Median
- 2.13
- Q1
- 1.10
- Min
- 0.03
P/B Ratio (MRQ)
On P/B ratio, both Align (ALGN) at 2.73 and Edwards Lifesciences (EW) at 5.41 are valued close to their industries’ norm against book — neither stands out from peers.
ALGN
Health Care Equipment & Services industry group
2.73
- Max
- 11.68
- Q3
- 6.12
- Median
- 3.00
- ALGN
- 2.73
- Q1
- 1.73
- Min
- -1.31
EW
Health Care Equipment & Services industry group
5.41
- Max
- 11.68
- Q3
- 6.12
- EW
- 5.41
- Median
- 3.00
- Q1
- 1.73
- Min
- -1.31
Valuation Metrics
| Metric | ALGN | EW |
|---|---|---|
| P/E Ratio (TTM) | 24.20 | 59.38 |
| P/S Ratio (TTM) | 2.81 | 8.80 |
| P/B Ratio (MRQ) | 2.73 | 5.41 |
| Free Cash Flow Yield (TTM) | 4.90% | 1.95% |